AbCellera Biologics Inc.

AbCellera Biologics Inc.verified

ABCL

Price:

$2.73

Market Cap:

$804.44M

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.[Read more]

Industry

Biotechnology

IPO Date

2020-12-11

Stock Exchange

NASDAQ

Ticker

ABCL

The Current Ratio as of November 2024 (TTM) for AbCellera Biologics Inc. (ABCL) is 10.96

According to AbCellera Biologics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.96. This represents a change of 27.51% compared to the average of 8.60 of the last 4 quarters.

AbCellera Biologics Inc. (ABCL) Historical Current Ratio (quarterly & annually)

How has ABCL Current Ratio performed in the past?

The mean historical Current Ratio of AbCellera Biologics Inc. over the last ten years is 5.07. The current 10.96 Current Ratio has changed 21.51% with respect to the historical average. Over the past ten years (40 quarters), ABCL's Current Ratio was at its highest in in the September 2021 quarter at 16.22. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

5.07

Median

7.33

Minimum

0

Maximum

8.67

AbCellera Biologics Inc. (ABCL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AbCellera Biologics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Current Ratio = 8.67

Minimum Annual Increase = -32.07%

Minimum Annual Current Ratio = 0

Quarterly (TTM)
Annual
YearCurrent RatioChange
20237.33-15.46%
20228.6712.49%
20217.70-1.96%
20207.86390.85%
20191.60-32.07%
20182.36Infinity%

AbCellera Biologics Inc. (ABCL) Average Current Ratio

How has ABCL Current Ratio performed in the past?

The current Current Ratio of AbCellera Biologics Inc. (ABCL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

7.90

5-year avg

6.63

10-year avg

5.07

AbCellera Biologics Inc. (ABCL) Current Ratio vs. Peers

How is ABCL’s Current Ratio compared to its peers?

AbCellera Biologics Inc.’s Current Ratio is less than CohBar, Inc. (15.69), greater than Hepion Pharmaceuticals, Inc. (5.62), greater than Rain Therapeutics Inc. (5.58), greater than Krystal Biotech, Inc. (9.50), less than AVROBIO, Inc. (26.17), greater than CureVac N.V. (2.29), greater than Reata Pharmaceuticals, Inc. (3.21), less than Vir Biotechnology, Inc. (12.51), greater than Propanc Biopharma, Inc. (0.01), greater than PTC Therapeutics, Inc. (2.23), greater than Sarepta Therapeutics, Inc. (3.90), greater than Iovance Biotherapeutics, Inc. (5.15), greater than Madrigal Pharmaceuticals, Inc. (5.98),

Build a custom stock screener for AbCellera Biologics Inc. (ABCL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbCellera Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AbCellera Biologics Inc. (ABCL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AbCellera Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is AbCellera Biologics Inc.'s Current Ratio?

How is the Current Ratio calculated for AbCellera Biologics Inc. (ABCL)?

What is the highest Current Ratio for AbCellera Biologics Inc. (ABCL)?

What is the 3-year average Current Ratio for AbCellera Biologics Inc. (ABCL)?

What is the 5-year average Current Ratio for AbCellera Biologics Inc. (ABCL)?

How does the current Current Ratio for AbCellera Biologics Inc. (ABCL) compare to its historical average?